Mead Johnson Nutrition Statement on Discussions with Reckitt Benckiser plc

GLENVIEW, Ill.–(BUSINESS WIRE)–While it is the longstanding policy of Mead Johnson Nutrition (NYSE:MJN)
not to comment on market speculation or rumors, in response to media
reports and a subsequent statement released by Reckitt Benckiser plc
(RB), the company confirms that it is in discussions with RB with
respect to its proposal to acquire the outstanding shares of MJN for $90
per share in cash.

Mead Johnson notes that no agreement has been completed, and there are
no assurances that any transaction will result from these discussions.
The company does not intend to make any additional comments regarding
this matter unless and until a formal agreement has been reached or
discussions have been terminated.

Mead Johnson remains committed to doing what is best for its
shareholders, employees and, as always, the children, families and
health care professionals around the world who trust and depend on its
products and expertise.

Forward-Looking Statements

This news release contains certain statements with respect to a possible
transaction involving Mead Johnson and Reckitt Benckiser that are
forward-looking as defined in the Private Securities Litigation Reform
Act of 1995. These forward-looking statements may be identified by the
fact they use words such as “should,” “expect,” “anticipate,”
“estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,”
“believe” and other words and terms of similar meaning and expression.
Forward-looking statements can also be identified by the fact that they
do not relate strictly to historical or current facts. Such
forward-looking statements are based on current expectations that
involve inherent risks, uncertainties and assumptions that may cause
actual results to differ materially from expectations as of the date of
this news release. These risks include, but are not limited to: (1) the
possibility that a possible transaction will not be pursued or fails to
be consummated; (2) adverse effects on the market price of Mead
Johnson’s common stock and on Mead Johnson’s operating results because
of a failure to enter into or complete the possible transaction; (3)
negative effects relating to the announcement of the possible
transaction or any further announcements relating to the possible
transaction or the entrance into or consummation of the possible
transaction on the market price of Mead Johnson’s stock; (4) the ability
to sustain brand strength, particularly the Enfa family of brands; (5)
the effect on the company’s reputation of real or perceived quality
issues; (6) the effect of regulatory restrictions related to the
company’s products; (7) the adverse effect of commodity costs; (8)
increased competition from branded, private label, store and
economy-branded products; (9) the effect of an economic downturn on
consumers’ purchasing behavior and customers’ ability to pay for
product; (10) inventory reductions by customers; (11) the adverse effect
of changes in foreign currency exchange rates; (12) the effect of
changes in economic, political and social conditions in the markets
where we operate; (13) changing consumer preferences; (14) the
possibility of changes in the Women, Infants and Children (WIC) program
or participation in WIC; (15) legislative, regulatory or judicial action
that may adversely affect the company’s ability to advertise its
products, maintain product margins, or negatively impact the company’s
reputation or result in fines or penalties that decrease earnings; and
(16) the ability to develop and market new, innovative products. For
additional information regarding these and other factors, see the
company’s filings with the United States Securities and Exchange
Commission (the “SEC”), including its most recent Annual Report on Form
10-K, which filings are available upon request from the SEC or at www.meadjohnson.com.
The company cautions readers not to place undue reliance on any
forward-looking statements, which speak only as of the date made. The
company undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops,
manufactures, markets and distributes more than 70 products in over 50
markets worldwide. The company’s mission is to nourish the world’s
children for the best start in life. The Mead Johnson name has been
associated with science-based pediatric nutrition products for over 110
years. The company’s “Enfa” family of brands, including
Enfamil® infant formula, is a world leading brand franchise
in pediatric nutrition.

For additional information on the company, you can go to www.meadjohnson.com.

Contacts

Mead Johnson Nutrition
Media
Christopher
Perille
1.847.832.2178
chris.perille@mjn.com
or
Investors
Kathy
MacDonald
1.847.832.2182
kathy.macdonald@mjn.com